Abstract
Aim Thromboangiitis Obliterans (TAO), or Buerger’s disease, affects peripheral vessels and is linked to smoking. This Diffusion tensor imaging tractography (DTI) study examines brain function changes in TAO patients compared to healthy smokers and non-smokers, aiming to reveal neurological implications beyond the known peripheral effects.
Methods The case-control study involved 50 participants aged 27-56 in northeast Iran, including TAO patients, healthy smokers, and non-smoking controls. MRI scans with DTI were conducted to assess 21 brain tracts for fractional anisotropy (FA) and apparent diffusion coefficient (ADC).
Results Significant differences in brain tract integrity were observed among the groups. TAO patients showed lower FA values in the minor forceps compared to healthy smokers, while smokers had higher FA values than non-smoking controls. ADC values were notably higher in TAO patients across several tracts, including corticospinal tracts, fornix tracts, arcuate fasciculus, and inferior longitudinal fasciculus, compared to both healthy smokers and controls.
Conclusion The study highlights distinct brain tract alterations in TAO patients and suggests potential neurological consequences associated with the disease and smoking habits. DTI proves valuable in understanding microstructural brain changes and could serve as a diagnostic tool for evaluating smoking-related neurologic complications, providing insights into TAO’s impact beyond peripheral vessels.
Key Points
Advanced MRI techniques, particularly DTI, reveal significant differences in fractional anisotropy (FA) and apparent diffusion coefficient (ADC) in the brains of individuals with Buerger’s disease and smokers.
Notable ADC variations in corticospinal and fornix tracts are observed between Buerger’s patients, smokers, and non-smokers.
FA values in the superior longitudinal fasciculus and the minor and major forceps significantly differ among Buerger’s patients, smokers, and controls, highlighting microstructural brain alterations.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
kashan University of medical science
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical Approval: This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. The ethics committee of Kashan University of Medical Sciences approved the protocol (Ethical Code: IR.KAUMS.MEDNT.REC.1397.049), ensuring that all procedures adhered to internationally recognized ethical standards for research involving human subjects.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
